Incidence and Patient Characteristics of Newly Diagnosed Hereditary Transthyretin Amyloidosis-Polyneuropathy in the Medicare Fee-for-Service Population: Variation by Race/Ethnicity, Income, and Geography (P5-2.009)
To understand how patient characteristics (race/ethnicity, income, and U.S. region of residence) influence disease severity at diagnosis, treatment rates, and time to treatment with ATTR-specific drugs of Medicare fee-for-service (FFS) patients with hereditary transthyretin amyloid-polyneuropathy (ATTRv-PN).
Authors
- Carol Bazell
- John Venditto
- Mia A. Papas (ORCID: https://orcid.org/0000-0001-8636-411X)
- José Nativi Nicolau
- Maggie Alston
Institutions
- WinnMed (US)
- AstraZeneca (Brazil) (BR)
- Milliman (United States) (US)
Publication Details
- Journal
- Neurology
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1212/wnl.0000000000210643
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00